These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
324 related articles for article (PubMed ID: 30246641)
1. Formulation and in-vivo Evaluation of Novel Topical Gel of Lopinavir for Targeting HIV. Ansari H; Singh P Curr HIV Res; 2018; 16(4):270-279. PubMed ID: 30246641 [TBL] [Abstract][Full Text] [Related]
2. A hybrid design to optimize preparation of lopinavir loaded solid lipid nanoparticles and comparative pharmacokinetic evaluation with marketed lopinavir/ritonavir coformulation. Ravi PR; Vats R; Dalal V; Murthy AN J Pharm Pharmacol; 2014 Jul; 66(7):912-26. PubMed ID: 24697749 [TBL] [Abstract][Full Text] [Related]
5. Formulation and Optimization of Topical Solid Lipid Nanoparticles based Gel of Dapsone Using Design of Experiment. Deshkar SS; Bhalerao SG; Jadhav MS; Shirolkar SV Pharm Nanotechnol; 2018; 6(4):264-275. PubMed ID: 30394227 [TBL] [Abstract][Full Text] [Related]
6. Development of Domperidone Solid Lipid Nanoparticles: In Vitro and In Vivo Characterization. Shazly GA; Alshehri S; Ibrahim MA; Tawfeek HM; Razik JA; Hassan YA; Shakeel F AAPS PharmSciTech; 2018 May; 19(4):1712-1719. PubMed ID: 29532427 [TBL] [Abstract][Full Text] [Related]
7. Solid lipid nanoparticles (SLNs) gels for topical delivery of aceclofenac in vitro and in vivo evaluation. Dasgupta S; Ghosh SK; Ray S; Mazumder B Curr Drug Deliv; 2013 Dec; 10(6):656-66. PubMed ID: 24274634 [TBL] [Abstract][Full Text] [Related]
8. Formulation of niosomal gel for enhanced transdermal lopinavir delivery and its comparative evaluation with ethosomal gel. Patel KK; Kumar P; Thakkar HP AAPS PharmSciTech; 2012 Dec; 13(4):1502-10. PubMed ID: 23104306 [TBL] [Abstract][Full Text] [Related]
9. Modified pullulan nanoparticles for oral delivery of lopinavir: formulation and pharmacokinetic evaluation. Ravi PR; Vats R; Balija J; Adapa SP; Aditya N Carbohydr Polym; 2014 Sep; 110():320-8. PubMed ID: 24906762 [TBL] [Abstract][Full Text] [Related]
10. Solid lipid nanoparticles (SLN) as carriers for the topical delivery of econazole nitrate: in-vitro characterization, ex-vivo and in-vivo studies. Sanna V; Gavini E; Cossu M; Rassu G; Giunchedi P J Pharm Pharmacol; 2007 Aug; 59(8):1057-64. PubMed ID: 17725847 [TBL] [Abstract][Full Text] [Related]
11. Systematic development of solid self-nanoemulsifying oily formulations (S-SNEOFs) for enhancing the oral bioavailability and intestinal lymphatic uptake of lopinavir. Garg B; Katare OP; Beg S; Lohan S; Singh B Colloids Surf B Biointerfaces; 2016 May; 141():611-622. PubMed ID: 26916320 [TBL] [Abstract][Full Text] [Related]
12. Skin targeting of resveratrol utilizing solid lipid nanoparticle-engrossed gel for chemically induced irritant contact dermatitis. Shrotriya SN; Ranpise NS; Vidhate BV Drug Deliv Transl Res; 2017 Feb; 7(1):37-52. PubMed ID: 27981502 [TBL] [Abstract][Full Text] [Related]
13. Novel Solid Lipid Nanocarrier of Glibenclamide: A Factorial Design Approach with Response Surface Methodology. Pandey S; Patel P; Gupta A Curr Pharm Des; 2018; 24(16):1811-1820. PubMed ID: 29788881 [TBL] [Abstract][Full Text] [Related]
14. Fluconazole-loaded solid lipid nanoparticles topical gel for treatment of pityriasis versicolor: formulation and clinical study. El-Housiny S; Shams Eldeen MA; El-Attar YA; Salem HA; Attia D; Bendas ER; El-Nabarawi MA Drug Deliv; 2018 Nov; 25(1):78-90. PubMed ID: 29239242 [TBL] [Abstract][Full Text] [Related]
15. Lipid nanoparticles for transdermal delivery of flurbiprofen: formulation, in vitro, ex vivo and in vivo studies. Bhaskar K; Anbu J; Ravichandiran V; Venkateswarlu V; Rao YM Lipids Health Dis; 2009 Feb; 8():6. PubMed ID: 19243632 [TBL] [Abstract][Full Text] [Related]
16. Development of solid lipid nanoparticles (SLNs) of lopinavir using hot self nano-emulsification (SNE) technique. Negi JS; Chattopadhyay P; Sharma AK; Ram V Eur J Pharm Sci; 2013 Jan; 48(1-2):231-9. PubMed ID: 23153618 [TBL] [Abstract][Full Text] [Related]
17. Development and evaluation of topical formulation containing solid lipid nanoparticles of vitamin A. Pople PV; Singh KK AAPS PharmSciTech; 2006; 7(4):91. PubMed ID: 17285742 [TBL] [Abstract][Full Text] [Related]
18. Development and in vivo evaluation of an innovative "Hydrochlorothiazide-in Cyclodextrins-in Solid Lipid Nanoparticles" formulation with sustained release and enhanced oral bioavailability for potential hypertension treatment in pediatrics. Cirri M; Mennini N; Maestrelli F; Mura P; Ghelardini C; Di Cesare Mannelli L Int J Pharm; 2017 Apr; 521(1-2):73-83. PubMed ID: 28229944 [TBL] [Abstract][Full Text] [Related]
19. Topical Amphotericin B solid lipid nanoparticles: Design and development. Butani D; Yewale C; Misra A Colloids Surf B Biointerfaces; 2016 Mar; 139():17-24. PubMed ID: 26700229 [TBL] [Abstract][Full Text] [Related]
20. Topical gel of Metformin solid lipid nanoparticles: A hopeful promise as a dermal delivery system. Rostamkalaei SS; Akbari J; Saeedi M; Morteza-Semnani K; Nokhodchi A Colloids Surf B Biointerfaces; 2019 Mar; 175():150-157. PubMed ID: 30530000 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]